Use of Doppler ultrasound in the evaluation of breast carcinoma

Seminars in Ultrasound CT and MRI

Volumn 21, Issue 4, 2000, Pages 297-307

  Mehta, Tejas S ^a   Raza, Sughra ^a   Baum, Janet K ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM;

ANGIOGENESIS; ARTICLE; BREAST CARCINOMA; CANCER DIAGNOSIS; CANCER GRADING; CANCER INVASION; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DOPPLER ECHOGRAPHY; HUMAN; IMAGE ENHANCEMENT; LYMPH NODE METASTASIS; PRIORITY JOURNAL; TUMOR VASCULARIZATION;

EID: 0033819056     PISSN: 08872171     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0887-2171(00)90024-6     Document Type: Article

References (99)

1. Mammography: Positive predictive value and true positive biopsy rate
2. Enhancement of true positive rates for nonpalpable carcinoma of the breast through mammographic selection
3. The prevalence of carcinoma in palpable versus impalpable mammographically detected lesions
4. Biopsy of occult breast lesions: Analysis of 1261 abnormalities
5. The role of ultrasound in breast cancer screening. A consensus statement by the European group for breast cancer screening
6. Sonography of the breast
7. Solid breast nodules: Use of sonography to distinguish between benign and malignant lesions
8. Automated water-path full breast sonography: Correlation with histology in 176 solid lesions
9. Fibroadenoma of the breast: Sonomammography correlated with pathology in 122 patients
10. Ultrasound analysis of 104 primary breast carcinomas classified according to histopathologic type
11. Fibroadenoma of the breast: Sonographic appearance
12. Diagnostic value of different interpretative criteria in real-time sonography of the breast
13. Classification and diagnostic criteria in breast echography
14. Specificity of ultrasonography in the diagnosis of benign breast masses
15. The spectrum of sonographic findings of fibroadenoma of the breast
16. Induction of angiogenesis during the transition from hyperplasia to neoplasia
17. Angiogenesis: Mechanistic insights, neovascular diseases, and therapeutic prospects
18. Tumor angiogenesis: Therapeutic implications
19. How is blood vessel growth regulated in normal and neoplastic tissue? GHA Clowes Memorial Award Lecture
20. Power versus conventional color Doppler sonography: Comparison in the depiction of normal intrarenal vasculature
21. Power Doppler US: A potentially useful alternative to mean frequency-based color Doppler US
22. Evaluation of solid breast lesions with power Doppler sonography
23. Measurement of blood perfusion in tissue using Doppler ultrasound
24. Influence of various instrument settings on the flow information derived from the power mode
25. Power Doppler expands standard color capacity
26. Breast masses: Color Doppler, power Doppler, and spectral analysis findings
27. Breast neoplasms: Duplex sonographic imaging as an adjunct in diagnosis
28. Solid breast lesions: Evaluation with power Doppler US
29. Breast diseases: Color Doppler US in differential diagnosis
30. Breast cancer vascularity: Color Doppler sonography and histopathology study
31. Occult breast carcinoma-use of color Doppler in localization
32. The use of duplex Doppler ultrasound in the diagnosis of breast cancer
33. Evaluation of breast tumors with color Doppler imaging: A comparison with image-directed Doppler ultrasound
34. High-resolution sonography of breast carcinoma
35. Tumor flow in malignant breast tumors measured by Doppler ultrasound: An independent predictor of survival
36. Comparison of various imaging methods with particular evaluation of color Doppler sonography for planning surgery for breast tumors
37. Microbubble contrast agent for color Doppler US: Effect on breast masses
38. Doppler ultrasound color flow imaging in the study of breast cancer: Preliminary findings
39. Color Doppler sonography in the evaluation of palpable breast masses
40. Color Doppler and duplex flow analysis for classification of breast lesions
41. Duplex sonography of mammary tumors: A prospective study of 75 patients
42. Breast tumors: Assessment of vascularity by colour Doppler
43. Color Doppler signals from breast tumors
44. Automated quantification of color Doppler signals: A preliminary study in breast tumors
45. The use of colour-coded and spectral Doppler ultrasound in the differentiation of benign and malignant breast lesions
46. New signs of breast cancer: High resistance flow and variations in resistive indices evaluation by color Doppler sonography
47. Breast tumors: Computer-assisted quantitative assessment with color Doppler US
48. Tumor angiogenesis
49. The value of arteriography in the diagnosis of bone tumours
50. Correlation of Doppler US tumor signals with neovascular morphology features
51. Vascularization of tumors: A review
52. Tumor angiogenesis and metastasis - Correlation in invasive breast carcinoma
53. Tumor angiogenesis: A new significant and independent prognostic indicator in early-stage breast carcinoma
54. Microvessel quantitation and prognosis in invasive breast carcinoma
55. Tumor microvessel density, p53 expression, tumor size, and peritumoral lymphatic vessel invasion are relevant prognostic markers in node-negative breast carcinoma
56. Tumor angiogenesis in node-negative breast carcinomas - Relationship with epidermal growth factor, estrogen receptor and survival
57. Prognostic value of intratumoral microvessel density, a measure of tumor angiogenesis, in node-negative breast carcinoma - Results of a multiparametric study
58. Tumor angiogenesis in breast cancer: Its importance as a prognostic indicator and the association with vascular endothelial growth factor expression
59. Microvessel density and vessel invasion in lymph-node negative breast cancer: Effect on recurrence-free survival
60. Colour Doppler sonography of breast masses: A multiparameter analysis
61. Color-coded and spectral Doppler flow in breast carcinomas - Relationship with the tumor microvasculature
62. Vascularity demonstrated by Doppler ultrasound and immunohistochemistry in invasive ductal carcinoma of the breast
63. Breast cancer angiogenesis: A quantitative morphologic and Doppler imaging study
64. Solid breast neoplasms: Differential diagnosis with pulsed Doppler ultrasound
65. Color Doppler flow as an indicator of nodal metastasis in solid breast masses
66. Power Doppler sonography of breast cancer: Does vascularity correlate with node status or lymphatic vascular invasion?
67. Colour Doppler ultrasonography studies of benign and malignant breast lesions
68. Blood flow in breast cancer and fibroadenoma estimated by colour Doppler ultrasonography
69. Edema of the arm as a function of the extent of axillary surgery in patients with stage I-II carcinoma of the breast treated with primary radiotherapy
70. Arm problems and psychological distress after surgery for breast cancer
71. Arm function after axillary dissection for breast cancer: A pilot study to provide parameter estimates
72. The sentinel node in breast cancer
73. Axillary node dissection in T1a breast carcinoma
74. The need to re-examine axillary lymph node dissection in invasive breast carcinoma
75. Real-time ultrasound, axillary mammography, and clinical examination in the detection of axillary lymph node metastases in breast cancer patients
76. Axillary lymph node metastases in breast cancer: Preoperative detection with US
77. Role of ultrasonography to detect axillary node involvement in operable breast cancer
78. Sonographic appearance of normal lymph nodes
79. Ultrasonic detection of lymph node metastases in the region around the celiac axis in esophageal and gastric cancer
80. Axillary lymph node metastases in breast cancer: Preoperative detection with US
81. Value of axillary ultrasonography and sonographically guided puncture of axillary nodes: A prospective study in 144 consecutive patients
82. Colour Doppler studies of axillary node metastases in breast carcinoma
83. Colour Doppler flow in normal axillary lymph nodes
84. Exuberant blood flow in enlarged lymph nodes: Findings on colour flow Doppler
85. Doppler ultrasound examination of pathologically enlarged lymph nodes
86. NIH concensus conference: Treatment of early-stage breast cancer
87. Primary (neoadjuvant) medical therapy
88. Assessment of response to therapy in advanced breast cancer
89. Mammography in the assessment of response to medical treatment of large primary breast cancer
90. Monitoring treatment response with color and power Doppler
91. Breast carcinoma: Measurement of tumor response to primary medical therapy with color Doppler flow Imaging
92. Vascular imaging with a three-dimensional power Doppler system
93. The 3D and 2D color flow display of breast masses
94. 3-D color Doppler image quantification of breast masses
95. Ultrasound contrast agents
96. Contrast agents in diagnostic ultrasound
97. Galactose-based intravenous sonographic contrast agent: Experimental studies
98. Doppler ultrasound in the diagnosis of breast lesions
99. Effects of a microbubble contrast agent on breast tumors: Computer-assisted quantitative assessment with color Doppler US - Early experience